Ian A. Mellis

Ian A. Mellis

Auto-generated profile, based on publicly available information

Ian A. Mellis

Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
AKAmanpreet Kaur
Amanpreet Kaur
BEBrett L. Ecker
Brett L. Ecker
SDStephen M. Douglass
Stephen M. Douglass
CKCurtis H. Kugel
Curtis H. Kugel
MWMarie R. Webster
Marie R. Webster
AWAshani T. Weeraratna
Ashani T. Weeraratna
Physical changes in skin are among the most visible signs of aging. We found that young dermal fibroblasts secrete high levels of extracellular matrix (ECM) constituents, including proteoglycans, glycoproteins, and cartilage-linking proteins. The most abundantly secreted was HAPLN1, a hyaluronic and proteoglycan link protein. HAPLN1 was lost in aged fibroblasts, resulting in a more aligned ECM that promoted metastasis of melanoma cells. Reconstituting HAPLN1 inhibited metastasis in an aged microenvironment, in 3-D skin reconstruction models, and in vivo. Intriguingly, aged fibroblast-derived matrices had the opposite effect on the migration of T cells, inhibiting their motility. HAPLN1 treatment of aged fibroblasts restored motility of mononuclear immune cells, while impeding that of polymorphonuclear immune cells, which in turn affected regulatory T-cell recruitment. These data suggest that although age-related physical changes in the ECM can promote tumor cell motility, they may adversely affect the motility of some immune cells, resulting in an overall change in the immune microenvironment. Understanding the physical changes in aging skin may provide avenues for more effective therapy for older patients with melanoma. Significance: These data shed light on the mechanochemical interactions that occur between aged skin, tumor, and immune cell populations, which may affect tumor metastasis and immune cell infiltration, with implications for the efficacy of current therapies for melanoma. See related commentary by Marie and Merlino, p. 19. This article is highlighted in the In This Issue feature, p. 1

12 November 2018 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
SRSara H Rouhanifard
Sara H Rouhanifard
IMIan A Mellis
Ian A Mellis
MDMargaret Dunagin
Margaret Dunagin
SBSareh Bayatpour
Sareh Bayatpour
CJConnie L Jiang
Connie L Jiang
ARArjun Raj
Arjun Raj

5 August 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AEAris Nikolaos Economides
Aris Nikolaos Economides
DFDavid Frendewey
David Frendewey
PYPeter Yang
Peter Yang
MDMelissa G. Dominguez
Melissa G. Dominguez
ADAnthony T. Dore
Anthony T. Dore
GYGeorge D. Yancopoulos
George D. Yancopoulos
Significance: We describe conditional by inversion (COIN), a new design for conditional alleles that uses an optimized conditional gene trap module (COIN module) inserted into the target gene in an orientation opposite to the gene’s direction of transcription. Activation by Cre recombinase inverts the COIN module, resulting in expression of a reporter and termination of transcription, thereby inactivating the target gene while marking the cells where the conditional event has occurred. Creation of COIN alleles for more than 20 genes showed that it is a robust and universal method—applicable to any gene regardless of exon–intron structure—that overcomes the limitations of previous conditional approaches.

12 June 2017 in Nature Methods
Verified
Journal Article
Open access
PDF file
IMIan A Mellis
Ian A Mellis
RGRohit Gupte
Rohit Gupte
ARArjun Raj
Arjun Raj
SRSara H Rouhanifard
Sara H Rouhanifard
Conversion of adenosine to inosine is a frequent type of RNA editing, but important details about the biology of this conversion remain unknown because of a lack of imaging tools. We developed inoFISH to directly visualize and quantify adenosine-to-inosine-edited transcripts in situ. We found that editing of the GRIA2, EIF2AK2, and NUP43 transcripts is uncorrelated with nuclear localization and paraspeckle association. Further, NUP43 exhibits constant editing levels between single cells, while GRIA2 editing levels vary.

9 January 2019 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
OSOrsolya Symmons
Orsolya Symmons
MCMarcello Chang
Marcello Chang
IMIan A Mellis
Ian A Mellis
JKJennifer M. Kalish
Jennifer M. Kalish
JPJihwan Park
Jihwan Park
ARArjun Raj
Arjun Raj
Extensive cell-to-cell variation exists even among putatively identical cells, and there is great interest in understanding how the properties of transcription relate to this heterogeneity. Differential expression from the two gene copies in diploid cells could potentially contribute, yet our ability to measure from which gene copy individual RNAs originated remains limited, particularly in the context of tissues. Here, we demonstrate quantitative, single molecule allele-specific RNA FISH adapted for use on tissue sections, allowing us to determine the chromosome of origin of individual RNA molecules in formaldehyde-fixed tissues. We used this method to visualize the allele-specific expression of Xist and multiple autosomal genes in mouse kidney. By combining these data with mathematical modeling, we evaluated models for allele-specific heterogeneity, in particular demonstrating that apparent expression from only one of the alleles in single cells can arise as a consequence of low-level mRNA abundance and transcriptional bursting. In mammals, most cells of the body contain two genetic datasets: one from the mother and one from the father, and—in theory—these two sets of information could contribute equally to produce the molecules in a given cell. In practice, however, this is not always the case, which can have dramatic implications for many traits, including visible features (such as fur color) and even disease outcomes. However, it remains difficult to measure the parental origin of individual molecules in a given cell and thus to assess what processes lead to an imbalance of the maternal and paternal contribution. We adapted a microscopy technique—called allele-specific single molecule RNA FISH—that uses a combination of fluorescent tags to specifically label one type of molecule, RNA, depending on its origin, for use in mouse kidney sections. Focusing on RNAs that were previously reported to show imbalance, we performed measurements and combined these with mathematical modeling to quantify imbalance in tissues and explain how these can arise. We found that we could recapitulate the observed imbalances using models that only take into account the random processes that produce RNA, without the need to invoke special regulatory mechanisms to create unequal contributions.

26 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YBYosef Berlyand
Yosef Berlyand
DWDaniel Weintraub
Daniel Weintraub
SXSharon X. Xie
Sharon X. Xie
IMIan A. Mellis
Ian A. Mellis
JDJimit Doshi
Jimit Doshi
ACAlice S. Chen-Plotkin
Alice S. Chen-Plotkin
Biomarkers from multiple modalities have been shown to correlate with cognition in Parkinson’s disease (PD) and in Alzheimer’s disease (AD). However, the relationships of these markers with each other, and the use of multiple markers in concert to predict an outcome of interest, are areas that are much less explored. Our objectives in this study were (1) to evaluate relationships among 17 biomarkers previously reported to associate with cognition in PD or AD and (2) to test performance of a five-biomarker classifier trained to recognize AD in identifying PD with dementia (PDD). To do this, we evaluated a cross-sectional cohort of PD patients (n = 75) across a spectrum of cognitive abilities. All PD participants had 17 baseline biomarkers from clinical, genetic, biochemical, and imaging modalities measured, and correlations among biomarkers were assessed by Spearman’s rho and by hierarchical clustering. We found that internal correlation among all 17 candidate biomarkers was modest, showing a maximum pairwise correlation coefficient of 0.51. However, a five-marker subset panel derived from AD (CSF total tau, CSF phosphorylated tau, CSF amyloid beta 42, APOE genotype, and SPARE-AD imaging score) discriminated cognitively normal PD patients vs. PDD patients with 80% accuracy, when employed in a classifier originally trained to recognize AD. Thus, an AD-derived biomarker signature may identify PDD patients with moderately high accuracy, suggesting mechanisms shared with AD in some PDD patients. Based on five measures readily obtained during life, this AD-derived signature may prove useful in identifying PDD patients most likely to respond to AD-based crossover therapies.